About Volta Medical
Volta Medical is a medical device company specializing in artificial intelligence solutions for cardiac electrophysiology, with a particular focus on complex atrial fibrillation (AF) and atrial tachycardia (AT). The company's mission is to aid in the assessment of complex arrhythmia pathologies through data-inspired AI technology. Volta has developed the VoltaPlex data collection and enrichment ecosystem for curated electrophysiology lab data, which feeds into a physician-validated machine learning methodology to support EP solutions. This framework has resulted in Volta's flagship product, Volta AF-Xplorer™ II, a Companion AI technology designed for real-time assessment of complex AF and AT. The system assists operators in the real-time manual or automatic annotation of 3D anatomical and electrical maps of human atria, identifying areas exhibiting spatiotemporal dispersion during atrial fibrillation or atrial tachycardia. Volta's technology addresses a critical clinical need: determining the right ablation approach for persistent AF, where clinical success rates in landmark studies are only approximately 50%. The company's AI can match the expertise of multi-year-trained electrophysiologists to analyze intracardiac atrial electrograms in real time and identify areas of interest potentially involved in the arrhythmia mechanism. Volta serves electrophysiologists and cardiac care providers treating complex substrate patients, including those with persistent AF, redo patients with pulmonary vein isolation, women with AF, and heart failure patients. The company has established one of the most ambitious clinical programs focused on the underserved complex AF patient population, including the landmark TAILORED-AF randomized controlled trial published in Nature Medicine.
Mission & Story
Mission
Volta's mission is to aid in the assessment of complex arrhythmia pathologies
Clinical Focus
Medical conditions and clinical areas addressed by Volta Medical.
Who It Serves
Milestones & Awards
Recent Milestones
TAILORED-AF randomized controlled trial published in Nature Medicine (2025), RESTART Trial completed (2026), FDA clearance obtained, CE mark obtained, global headcount expected to reach nearly 100 team members by end of 2023
Social & Media
Latest Updates
Company Details
- Employees
- 51-200
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.